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Abstract
Background: Negative symptoms of schizophrenia are frequently associated with poor long term outcomes.
Established interventions have little, if any, positive effects on negative symptoms. Arts Therapies such as Body
Psychotherapy (BPT) have been suggested to reduce negative symptoms, but the existing evidence is limited. In a
small exploratory trial a manualised form of group BPT led to significantly lower negative symptom levels both at
the end of treatment and at 4 months follow-up as compared to supportive counseling. We designed a large
multi-site trial to assess the effectiveness of a manualised BPT intervention in reducing negative symptoms,
compared to an active control.
Methods/Design: In a randomised controlled trial, 256 schizophrenic outpatients with negative symptoms will be
randomly allocated either to BPT or Pilates groups. In both conditions, patients will be offered two 90 minutes
sessions per week in groups of about 8 patients over a period of 10 weeks. Outcomes are assessed at the end of
treatment and at six months follow-up. The primary outcome is severity of negative symptoms, as measured by the
Positive and Negative Symptom Scale (PANSS), whilst a range of secondary outcome measures include general
psychopathology, social contacts, and quality of life. We will also assess the cost-effectiveness of the intervention.
Discussion: The study aims to evaluate the effectiveness of a promising form of group therapy which may help
alleviate negative symptoms that are associated with unfavourable long-term outcomes and have so far been
difficult to treat. If the trial is successful, it will add a new and effective option in the treatment of negative
symptoms. Group BPT is manualised, might be attractive to many patients because of its unusual approach, and
could potentially be rolled out to services at relatively little additional cost.
Trial registration: Current Controlled Trials ISRCTN84216587
Background
Despite improvements of anti-psychotic medication and
psychological treatments, schizophrenia patients often
experience persistent symptoms and full remissions are
infrequent. Patients often do not adhere to existing
pharmacological and psychological treatments and even
when they do, currently available treatments have an
only limited effect. This applies in particular to negative
symptoms which are frequently associated with poor
long term outcomes.
The National Institute for Clinical Excellence (NICE)
reviewed the literature on the treatment of negative
symptoms and identified six trials using different forms
of ‘arts therapies’. Arts therapies is an umbrella term
including therapies that have central non-verbal compo-
nents, such as Body Psychotherapy (BPT). NICE
suggested that arts therapies are effective in reducing
negative symptoms as compared to any other control.
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The Guideline Development Group recommended that
“further large-scale investigations of arts therapies
should be undertaken to increase the current evidence
base” [1] (p199). In particular, “an adequately powered
trial should be conducted to investigate the clinical and
cost-effectiveness of arts therapies as compared to an
active control in people with schizophrenia” [1] (p200).
BPT refers back to a long tradition in psychiatry. A
first trial in schizophrenia patients was published in 1965
showing a significant improvement of the treatment group,
as compared to controls in affective contact, motility and
general functioning [2]. Four further controlled studies -
three of them randomised - compared forms of BPT with
non-specific attention, music therapy or fitness training.
The results suggest favourable effects of the experimental
treatments on a range of outcome variables, including
some indicators of negative symptoms [2-5]. However, all
these studies, which were exclusively conducted before
1980, have serious methodological shortcomings such as
small sample sizes, vaguely defined outcome criteria, no
systematic assessment of psychopathology, no recording of
medication, and no intention-to-treat analysis.
A more recent exploratory randomised controlled trial
tested manualised BPT in out-patients with persistent
negative symptoms of schizophrenia [6]. Compared to a
control group receiving supportive counselling, patients in
the experimental group showed a significant improvement
of negative symptoms. The effect size was large, and main-
tained at a 4 month follow up. The major limitations of that
study were that it was a small exploratory trial based at one
site and with only one BPT therapist, and that the control
condition was supportive counselling, which turned out to
be unattractive to patients and meant that the non-specific
effects of physical activity could not be controlled for. In
addition, the exploratory study did not provide sufficient
evidence for the cost-effectiveness of BPT. Following these
findings, an open uncontrolled trial of manualised BPT was
conducted by the same authors with different therapists
which yielded similar results [7], however to date there have
been no other rigorous trials on BPT or a similar method
in the treatment of schizophrenia [8].
The specific components of the BPT under investigation
are a) the focus on body experience at a cognitive and
emotional level b) the facilitation of emotional group inter-
actions, and c) the link between movement and emotion.
The manual for BPT [9], which was applied in the explora-
tory trial and will also be used in this pragmatic trial,
intends to utilise the three specific mechanisms. Common
components utilised in both interventions will include the
non-specific effects of non-emotional group interactions,
therapist/instructor attention, and physical activity.
In a review into physical exercise for schizophrenia
[10], physical activity groups were found to significantly
improve depression scores and negative symptoms in
comparison to treatment as usual, but in a study which
used physical activities as an active control designed to
evaluate the effectiveness of yoga therapy [11] yoga was
found to result in a significantly greater reduction in
negative symptoms in comparison to physical activity
alone. This study suggests that physical activity groups
can be used as an active control, fulfilling the requirement
laid down by NICE for a ‘sham condition’, but with physical
activity groups being found to have a significant effect on
negative symptoms this study may under-report any effect
of the intervention compared to the usual treatment
patients are likely to receive.
Beyond the expected clinical effectiveness, there are
three characteristics of BPT that make it particularly
beneficial for service providers: 1) as a group based
method, BPT is relatively inexpensive; 2) BPT can be
flexibly combined with other treatment methods including
all pharmacological interventions; 3) because BPT is so
distinct from conventional treatment methods, it can
appeal to patients who are difficult to engage in other
forms of treatment. The latter point is underlined by
findings of a qualitative evaluation of the exploratory
trial [7] in which patients fed back most positively about
both its focus and methods.
Methods
Study Design
In a randomised controlled trial, schizophrenia patients
with negative symptoms will be randomly allocated to
groups for BPT or Pilates as an active control. Both
conditions are in addition to treatment as usual and will
be delivered in groups of about 8 patients each. There
will be 3 data collection points; before treatment, after
the 10 week treatment period, and after a 6 month
follow-up period. Each therapist in either condition will
run a maximum of two groups, and in each group they
will be assisted by a co-facilitator. The trial cannot be
fully “blind” because clinicians and patients cannot be
masked towards the allocation of the patients to the
experimental or control group. However, researchers
who conduct the outcome assessments will be masked
to the allocation of patients, and the eligibility and baseline
assessments will occur pre-randomisation. All the analysis
will be conducted blind to the participant allocation.
Originally, the plan was to randomise 16 patients at a
time in each site, eight to intervention and eight to
control, but this was changed for logistic reasons. We
will now recruit a larger number, i.e. up to 20 patients in
one batch, to ensure we have a sufficient number of
participants randomised to cover any dropout between
the eligibility and baseline assessment phases. After the
baseline assessments, participants will be randomly allo-
cated to the intervention or control group in batches
using randomly permuted blocks of 4 and 6, starting
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each batch at the start of a new block to preserve
balance. Conducting the randomisation in this manner
allows us to randomise all the participants in one batch
either at the same time or over two time points, allowing
the research team more time to finalise the logistics
involved with getting all the participants to the groups at
the correct times.
BPT and Pilates groups will both run for 10 weeks.
After the 10 week intervention period and after a further
6 month follow-up patients will be interviewed by the
researchers and outcomes will be assessed. These assess-
ments will be conducted either on NHS sites or in the
community, ideally in the same location as the original
assessments.
Planned interventions
Patients in the experimental group will receive 20 sessions
of BPT which will be delivered in groups of approximately
8 patients over a 10 week period. Each session will take
90 minutes.
BPT is manualised with the following components: 1)
overcoming communication barriers through non-verbal
techniques; 2) re-focussing cognitive and emotional
awareness towards the body; 3) stimulating activity and
emotional responsiveness; 4) exploring physical potentials;
5) focussing on strength and experiencing the body as a
source of creativity, reliability, pleasure and self-expression;
6) modifying dysfunctional self-perception and addressing
body-related psychopathological features such as bound-
ary loss, somatic depersonalisation, and body schema
disturbances.
Each BPT session contains five discrete sections; 1) the
opening circle, which is used to describe feelings and
energy levels; 2) a warm-up section, where participants
stand in a circle and warm up using different body parts
and movements; 3) a structured task section, which
includes exercises such as mirroring each other’s move-
ments and creating body image sculpture in partners; 4)
a creative movements section, which includes exercises
such as creating group sculptures and reflecting on
perceptions and emotions; 5) a closing circle, used to
reflect on the group experience and to refocus on the
self with body oriented exercises. More detail on this is
available in the manual [9].
All therapists will be accredited dance-movement
psychotherapists with additional training in applying the
manual of body psychotherapy for patients with negative
symptoms of schizophrenia, as it was used in the
exploratory trial [6]. Regular supervision will be provided
3 times within each 10 week treatment period. Adherence
to the manual will be assessed by the author of the manual
based on videotapes of the sessions.
The active control condition of Pilates groups will be
delivered with the same frequency and length of sessions
and overall duration as BPT, i.e. there will be two
sessions per week over a ten week period and each
session will last up to 90 minutes. Pilates groups will be
described to patients as a fitness and physical health
intervention so that in the recruitment process patients
consent to participate in one of two interventions that
share several elements, most importantly the format and
physical activities. This is intended to limit the risk of
different acceptance rates of the two interventions once
patients are informed about their allocation.
The venues for the Pilates groups will be similar
rooms as those used for BPT. Pilates groups will be
delivered by qualified instructors supported by a co-fa-
cilitator, and follow the established guidelines for such
groups. A brief manual for the Pilates groups was
written by qualified instructors involved in the trial, in
collaboration research team, using the Pilates Union
Matwork Manual as a guide [12]. The Trial manual
contains instructions on how to run the groups, as well
as references to material describing the exercises in
detail. Group interactions will occur as they commonly
do when patients are together, but the instructor will
not actively encourage or structure them. Instructors
will pay attention to patients and respond to them
without addressing or verbalising emotions. As an
active control condition in this trial, Pilates will there-
fore provide moderate physical activity, instructor
attention and non-emotional group interaction, but
not the specific components of BPT which are the
focus on body experience, the facilitation of emotional
group interactions, and linking movement and emo-
tional experience. In both conditions the same therap-
ist or instructor will be in charge of a maximum of
two groups.
Inclusion criteria
The inclusion criteria for community patients receiving
mental health care in services in the National Health
Service (NHS) are as follows:
 Being aged between 18 and 65 years.
 Having an established diagnoses of schizophrenia
according to DSM-IV.
 Having had symptoms of schizophrenia for at least
6 months.
 Having Scores of ≥18 on the negative symptoms
subscale of the Positive and Negative Symptom
Scale; the PANSS [13].
 Not changing the type of anti-psychotic medication
prescribed for at least 6 weeks prior to recruitment
(although dosage may change).
 A willingness to participate in groups for BPT or
physical activity.
 An ability to give written informed consent.
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Exclusion criteria
The exclusion criteria are:
 Severe physical disability preventing patients from
participating in groups for BPT or Pilates.
 Insufficient command of English so that outcomes
cannot be reasonably assessed in English.
 A physical condition that makes participation in
either BPT or Pilates impossible or potentially.
harmful.
Outcome measures
The primary outcome criterion for the effectiveness of
BPT is the level of negative symptoms as assessed on the
PANSS [13].
The secondary outcomes are:
 The levels of general psychopathology and positive
symptoms, measured by the PANSS [13].
 Subjective quality of life, measured by the Manchester
Short Assessment of Quality of Life [14].
 A measure of the amount activities the participant
has engaged in during the previous week, using
items from the Time Use Survey [15].
 The participants level of treatment satisfaction in
the intervention, measured by the Client Satisfaction
Questionnaire [16].
 A measure of the participants objective social
situation, recorded by the SIX [17].
 Extrapyramidal symptoms, using the Simpson-Angus
Scale [18].
 A secondary measure of negative symptoms which
has been developed recently and attempts to
differentiate between measures of emotional
experience and emotional expression (Clinical
Assessment interview for Negative Symptoms; the
CAINS, [19]).
 A measure of nonverbal communication/gesture
behaviour, based on videotapes of the assessments
using the NEUROGES-ELAN system [20].
 A measure of Depression (the Calgary Depression
Scale [21]).
 The level of social contacts the participant has made
in the past month, measured through using sections
of the Social Network Scale [22].
 A measure of cost-effectiveness using the Client
Service Receipt Inventory (CSRI, [23]).
 A measure of Quality of life adjusted years, based on
the EQ-5D [24].
All criteria will be obtained at pre-treatment baseline,
at the end of treatment, and after a 6 month follow-up.
Our primary hypothesis relates to endpoints at the end
of treatment.
The number of therapy sessions attended by patients
in both groups will be recorded. Costs of BPT and
Pilates will be calculated taking into account the staff
time involved in delivering therapy, training received
and supervision (including time of both therapists and
those providing training/supervision). The training costs
will be apportioned over the period of time in the trial
during which therapy is delivered. However, the benefits
of training are likely to run beyond the trial and therefore
sensitivity analyses will involve apportioning training
costs over longer periods. Other service use information
(including health and social care inputs, medication and
informal care) will be collected for the 6 months prior to
treatment, the treatment period of 10 weeks, and the
6 month follow-up period using the CSRI [23]. Service
use data will be combined with nationally applicable unit
costs. Informal care costs will be based on the unit cost of
a homecare worker, with wage rates for employed carers
used as an alternative in sensitivity analyses. Costs will be
reported in line with NICE guidance.
Ethics Approval
The study has been approved by the Camden & Islington
National Research Ethics Committee (REC reference 10/
H0722/44). All data will be stored in line with the Data
Protection Act. All video-recorded data will be encrypted
and password protected.
Trial Steering Committee and Data Monitoring and Ethics
Committee
Both a Trial Steering Committee (TSC) and Data
Monitoring and Ethics Committee (DMEC) have been
established.
Recruiting participants and obtaining informed consent
In order to recruit participants clinicians will be asked
to screen their caseloads to identify those eligible and
appropriate for the study, and then to ask them for their
consent to be approached by a research assistant. If the
patient agrees, they will be contacted by a member of
the research team, fully informed about the study, and
asked for written informed consent. Once the participant
has consented, the researcher will then conduct the
eligibility assessment. Consent to take part in the trial
can be withdrawn at any time, without any negative
consequences, other than that patients would not have
the potential benefits of further participation in the BPT
or Pilates groups. As part of this process we will request
consent for the pre and post intervention PANSS &
CAINS interviews to be video recorded to enable inde-
pendent researcher ratings as well as further analysis of
the data. This is optional for patients, and if they do not
wish to be video-recorded this will not impact on their
participation in the study.
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Statistical analysis
The primary analysis will be an available case analysis
following intention to treat principles. We will use
mixed effect models as appropriate to the outcome, with
fixed effects for the intervention, baseline level of
outcome and centre, and random effects for therapy
groups. For continuous outcomes we will use Stata’s
xtmixed command, xtmepoisson for count outcomes,
and gllamm for ordinal outcomes. We will assess
whether there is a clustering effect due to therapist or
instructor (some therapists or instructors will lead two
groups), but will not take this element of clustering into
account in the analysis.
We will use sensitivity analyses to explore the impact
of any missing data, including extreme scenario sensitivity
analyses, for example that those who are lost to follow up
would have no improvement as result of any intervention.
If there are sufficient missing values to warrant its use, we
will use multiple imputation following an exploration
of patterns of missingness. We expect to use the MAR
(missing at random) assumption in this imputation. In
case group dropout (as opposed to study dropout) is
higher in one condition compared to the other, we will
conduct a simple complier-average causal analysis with
compliers defined by the active intervention. Compliance
will be defined as attendance of five or more sessions
of BPT.
Economic evaluation
Cost data comparisons between the groups will be
made using a bootstrap regression model (using 10,000
repetitions). Either bias-corrected or percentile 95%
confidence intervals will be reported depending on the
level of bias in the data. Cost-effectiveness and cost-utility
will be established by combining the cost data (NHS/PSS
and then all services) with change scores on the PANSS
and QALYs respectively. In addition, cost-effectiveness
acceptability curves (CEACs) will show the probability
that BPT or Pilates is cost-effective for different values
placed on unit-changes in outcome. The net benefit
approach will be used (i.e. the monetary value of outcome
change minus the service cost) and net benefit will
then be used in bootstrapped regression models. The
proportion of coefficients for each resample that are
above zero will indicate the probability that BPT is the
most cost-effective option. The values used for the
CEAC based on QALY gains will be £0 to £100,000 in
£5,000 increments, which includes the threshold of
£20,000 to £30,000 used by NICE. We will also report
values for PANSS improvements that are linked to
BPT/Pilates having a 50%, 75% and 95% likelihood of
being cost-effective.
Because this project uses an active control we are
essentially looking at the cost-effectiveness of receiving
BPT rather than Pilates. Both BPT and Pilates are deliv-
ered by a therapist/instructor and in groups so we will
be costing both interventions. However, in routine prac-
tice BPT is likely to be considered as an additional ser-
vice rather than as an alternative to other active
therapies. In sensitivity analyses we will therefore apply
lower unit costs (25%, 50%, 75% and 100% lower) for the
active control in an attempt to replicate routine practice
where no or limited physical activities are provided. In
case BPT could be delivered by other professionals who
are more or less expensive, we will also increase/decrease
the unit cost of BPT by 25% and 50% in sensitivity
analyses.
Proposed sample size
A 20% reduction in the PANSS negative scale has been
defined as clinically significant [25], which we would
anticipate to be a difference of approximately 3 points
given the eligibility criteria. To detect a difference of 3
points, with a standard deviation of 5, at alpha = 5%, and
a power of 90%, 58 patients are required in each arm.
Assuming an intra-cluster correlation coefficient for
treatment group of 0.1, and 7 patients per group with
analysable data at the end of treatment gives an inflation
factor of 1.6 [24] leading to a required sample size of
93 in each arm. At six months we expect a loss to
follow-up of 31%, resulting in 5.5 individuals per group
on average and an inflation factor of 1.45; recruiting
128 per arm (16 groups of 8 in each arm) leaves 88 per
arm at 6 months and 91% power to detect a difference
of 3 points at this time point (see Figure 1). One
hundred and twenty eight patients per arm, i.e. 16
groups of approximately 8 patients in each arm will
give 94% power for the end of treatment analysis. We
do not expect to recruit and allocate exactly eight indi-
viduals within each group but the variation in group
size will be small and will not materially affect the
power of the trial.
The estimated loss takes into account drop outs at
three different phases of the study, i.e. a) between first
interview and beginning of treatment, b) during
treatment, and c) during the six months follow up
period. Some patients will have to wait up to 5.5 months
between giving consent and beginning of treatment.
Within that period they could drop out because they
change their mind about participation or experience a
reduction of negative symptoms so they no longer meet
the inclusion criteria. Based on the exploratory trial and
clinical experiences in East London, we expect this drop-
out rate to be less than 10%. During the treatment phase
we will have drop outs from treatment in both groups.
In line with the intention to treat analysis we will try
and follow up all patients who dropped out of treatment
in either arm.
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In the exploratory trial, the dropout rate from ran-
domisation to 4 month follow-up was 35%. To achieve a
lower dropout rate despite a longer follow-up period as
compared to the exploratory trial, i.e. 6 instead of
4 month, we will take the following steps:
a) patients will be reimbursed for their expenses and
time for each research interview;
b) at each interview (other than the final one at the end
of the follow up period), research assistants will
already arrange the meeting for the next interview
and two weeks before the meeting send a reminder
to the patient;
c) the same research assistant will conduct all four
interviews with a patient so that a positive
relationship can be established;
d) research assistants will work full time on the study
so that they are flexible in accommodating the
patients’ wishes for meetings at specific times and at
specific places including the patients’ homes.
Discussion
At present there is some limited evidence to suggest that
BPT can help reduce the negative symptoms of schizophre-
nia. This is significant given these particular symptoms are
associated with poorer outcomes, and are resistant to most
other forms of treatment. The aim of this study is to build
on the current evidence base and examine the effectiveness
of BPT in a large multi-site trial, examining both the
effectiveness and cost-effectiveness in comparison to
an active control.
In comparison to the exploratory study which found a
strong effect of BPT on negative symptoms [6], the most
significant revision, other than the scale of the project,
has been to replace the previous control condition of
counselling with a structured Pilates group. This modifi-
cation will allow us to test whether it is the specific
components of BPT, i.e. the focus on body experience,
the facilitation of emotional group interactions, and the
link between movement and emotion, as opposed to the
physical activity and the group format which reduces
Patients identified as meeting inclusion criteria 
by clinicians
Patients not contacted for 
organisational reasons or no 
consent to be approached
Patients contacted by researchers
Patients excluded due to non-
consent or too low PANSS scores
Patients recruited
Loss to randomization
Patients assessed and 
randomised 50:50
Patients allocated to control group 
receiving Pilates and treatment as usual 
Patients allocated to intervention group 
receiving Body Psychotherapy and 
treatment as usual 
Loss from recruitment to 
end of treatment 
Loss from recruitment to 
end of treatment 
Patients assessed at end of 
treatment
Patients assessed at end of 
treatment
Loss from recruitment to 
6 month follow-up
Loss from recruitment to 
6 month follow-up
Patients interviewed at 6 
months follow-up 
Patients interviewed at 6 
months follow-up 
Figure 1 Flow Diagram.
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negative symptoms. One possible limitation of using
Pilates as a control however is that the non-specific
effects of a regular, structured group-intervention, with
group facilitator attention and supported attendance as
provided in Pilates groups is far from clear.
Implementing the trial design has a number of
challenges. By definition, patients experiencing severe
negative symptoms have high levels of social withdrawal
and low motivation to engage in activities, meaning it
might be very difficult to engage participants in study. In
addition, the validity of assessing negative symptoms
with established measures such as the PANSS has been
questioned [26], whilst newer scales developed to address
these concerns such as the CAINS [19] have not yet been
extensively used.
If the trial does demonstrate the effectiveness and
cost-effectiveness of BPT, then this could potentially
result in a major development in the treatment of
negative symptoms of schizophrenia. Qualified Dance
Movement Psychotherapists would require only minimal
additional training before they would be able to admin-
ister the treatment, and there are also qualified Body
Psychotherapists who are able to deliver BPT in groups.
Given that the intervention is manualised it can, in
theory, be delivered in a consistent and reliable manner.
Appropriate spaces as well as the required equipment
are likely to be available in most services. Thus, it
should be possible to roll out the intervention in the
NHS and in mental health services in other countries,
and widely offer group BPT to large numbers of patients
at limited costs.
In case the trial shows that BPT is effective, this will
also be a reason to explore in more depth the potential
therapeutic mechanisms involved in the treatment
process, such as the linked experience of movement and
emotion and the socio-therapeutic facilitation of group
interactions through the body oriented interventions. It
will also be important to see whether and, if so, to what
extent lower negative symptoms translate into improved
social contacts and a better quality of life. The latter issue
will be addressed in the analysis of secondary outcomes.
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